ArticleBlood neoplasia2025

Enitociclib, a selective CDK9 inhibitor: in vitro and in vivo preclinical studies in multiple myeloma.

Son Tran et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.